Grown Rogue International (GRUSF) Capital Leases (2009 - 2026)

Grown Rogue International (GRUSF) recorded quarterly Capital Leases of $51359.0 in Q1 2026, down 24.23% quarter-over-quarter from $67782.0 in Q4 2025.

Grown Rogue International (GRUSF) Capital Leases (2009 - 2026) Analysis & Trends

Grown Rogue International's Capital Leases history runs 9 years deep, the most recent figure standing at $51359.0 for Q1 2026.

  • In Q1 2026, Capital Leases changed N/A year-over-year to $51359.0; the TTM figure through Mar 2026 stood at $51359.0 (changed N/A YoY), while the FY2025 annual figure was $67782.0, changed N/A from the prior year.
  • Capital Leases was $51359.0 for Q1 2026 at Grown Rogue International, down from $67782.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $67782.0 in Q4 2025 to a low of $51359.0 in Q1 2026.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Grown Rogue International - - 3.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 51,359.00
Dec 31, 2025 67,782.00
Jul 31, 2020 72,908.00
Apr 30, 2020 95,087.00
Jan 31, 2020 104,130.00
Oct 31, 2019 129,876.00
Jul 31, 2019 138,162.00
Apr 30, 2019 136,767.00
Jan 31, 2019 103,371.00
Oct 31, 2018 99,134.00
Apr 30, 2018 149,321.00
Oct 31, 2017 82,810.00
May 31, 2011 30,163.90
Feb 28, 2011 20,833.92
Nov 30, 2010 981,078.97
Aug 31, 2010 985,617.32
Feb 28, 2010 294,169.33
Nov 30, 2009 319,153.74
Aug 31, 2009 300,618.51
May 31, 2009 679,750.75